GM-2505 explained

GM-2505 is an experimental psychedelic antidepressant that works as a 5-HT2A receptor agonist. Compared to other 5-HT2A receptor agonists, it has a shorter duration of action.[1] [2]

Notes and References

  1. Hughes . Zoe . Klein . Adam . Dvorak . Dino . Austin . Eric . Kiss . Laszlo . Marek . Gerard . Sporn . Jonathan . Kruegel . Andrew . 22. GM-2505 has Rapid Onset Antidepressant Activity and Causes Dose-Dependent Changes in qEEG With Increasing 5-HT2A Receptor Occupancy . Biological Psychiatry . May 2023 . 93 . 9 . S102–S103 . 10.1016/j.biopsych.2023.02.262. 258042180 .
  2. News: Beaney . Abigail . Gilgamesh to initiate Phase IIa trial of fast-acting psychedelic drug . 7 December 2023 . Clinical Trials Arena . 6 December 2023.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "GM-2505".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.